Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?

Is there any data to suggest one time-frame is better than the other?

The CDC states give "2024–2025 Dose 2 (Moderna, Novavax or Pfizer-BioNTech): 6 months (minimum interval 2 months) after 2024–2025 Dose 1".

Answer from: at Academic Institution

This is a complicated question and unfortunately, we have no clear answer for it based upon clinical outcome data. The COVID-19 pandemic has changed dramatically since its inception over 4 years ago. Based on a combination of favorable viral evolution of diminishing pathogenic potential continuing t...

Comments

at Uniformed Services University of the Health Sciences (USUHS)
@Leonard Calabrese: What a well-thought-out and co...

at Cleveland Clinic
Thanks!

Please select the option that best describes you:

Is it better to give dose 2 of the mRNA 2024-2025 Covid-19 vaccine at month 2 or month 6 after dose 1 in moderately immunocompromised patients?

Related Questions